The stock is now only up 6% after the best news the company has gotten in recent history of the FDA approving them for studies on a cutting edge cancer treatment.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.